The two businesses with which a Chinese man made $ 7 billion in a few months



[ad_1]

Asia has a new richer person thanks to a vaccine company and a water bottling company.

Zhong Shanshan has increased his fortune by $ 7 billion this year, surpassing Mukesh Ambani from India and Jack Ma from China.

He is worth $ 77.8 billion, making him the 11th richest person in the world, according to the Bloomberg Billionaires Index, cited by BBC News.

Also read: China produces five new billionaires a week. The richest Chinese have gained a record as much as Britain’s GDP

Nicknamed the “lone wolf,” Zhong’s work began in journalism, then continued with mushroom cultivation and medical care.

Zhong owns Beijing Wantai Biological, which produces vaccines, and in April he listed his shares on the Chinese stock market.

Three months later he did the same with Nongfu Spring, his Hong Kong-listed bottled water company. At the time, the move propelled him above Alibaba founder Jack Ma, who had previously been the richest person in China and Asia.

Nongfu Spring has become one of the strongest listings in Hong Kong and the company’s shares have risen 155%.

Shares of Beijing Wantai Biological, which contributes to the development of an anti-Covid vaccine, have increased by more than 2,000%.

This accelerated growth took Zhong to the top spot in Asia and is one of the fastest accumulations of wealth in history, according to Bloomberg.

The rich get even richer

Many of the richest people in the world increased their fortunes during the pandemic, including Amazon founder Jeff Bezos.

In India, Mukesh Ambani became rich with $ 18.3 billion and reached a fortune of $ 76.9 billion after concluding deals to turn his Reliance Industries conglomerate into a titan of technology and commerce. electronic. Earlier this year, Facebook announced that it was investing $ 5.7 billion in Indian mobile internet company Reliance Jio, owned by Ambani.

Jack Ma’s assets have fallen from $ 61.7 billion to $ 51.2 billion, while his Alibaba empire faces increased scrutiny from Chinese regulators.

Alibaba is under investigation on suspicion of monopoly behavior, while its subsidiary Ant Group blocked its listing on the stock exchange in November.

Most of China’s new billionaires come from the tech industry.

Publisher: DC

[ad_2]